Day: January 25, 2021

METTAWA, Ill., Jan. 25, 2021 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC) today announced that it is increasing production capacity at three of its global boat manufacturing facilities to meet unprecedented consumer demand and assist in replenishing historically low field inventory levels.Brunswick will reopen its 225,000 square-foot Palm Coast, Florida boat manufacturing facility to expand dedicated manufacturing capability for Boston Whaler products by an additional 40 percent. The Palm Coast facility, which has been inactive since 2018, was designed for the manufacture of large boats.  Since 2014, Boston Whaler has invested more than $60M manufacturing a full line of award-winning new products in addition to expanding manufacturing capacity by 75 percent during that time at its current 550,000 square-foot global headquarters...

TORONTO, Jan. 25, 2021 (GLOBE NEWSWIRE) — STORAGEVAULT CANADA INC. (“StorageVault” or the “Corporation”) (SVI-TSX-V) is pleased to announce that it has received conditional acceptance from the TSX Venture Exchange to renew its Normal Course Issuer Bid (“NCIB”) to purchase for cancellation, during the 12-month period starting January 25, 2021, up to 18,312,741 of the outstanding Common Shares of the Corporation, representing 5% of the Common Shares outstanding. In addition, the Corporation has received conditional acceptance from the TSX Venture Exchange to commence a NCIB to purchase for cancellation, during the 12-month period starting January 25, 2021, outstanding senior unsecured hybrid debentures of the Corporation (“Debentures”) in the aggregate principal amount of $3,750,000, representing 5% of the currently outstanding $75,000,000...

— If approved, First Oral Penem in the U.S. and First New Oral Treatment for uUTIs in Over 20 Years —— PDUFA goal date of July 25, 2021 —DUBLIN, Ireland and CHICAGO, Jan. 25, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that the U.S. Food and Drug Administration (FDA) accepted for review the New Drug Application (NDA) for sulopenem etzadroxil/probenecid (oral sulopenem) for the treatment of uncomplicated urinary tract infections (uUTIs) in patients with a quinolone non-susceptible pathogen. The FDA has designated this application as a priority review and consequently...

Charlotte, N.C., Jan. 25, 2021 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, will host an investor update call to provide a business update and outlook on Monday, February 1, 2021 at 8:00 a.m. Eastern Time. Management will host a question-and-answer session at the end of the call.To listen to the call by telephone, please dial 877-407-3982 (domestic) or 201-493-6780 (international). The conference call will be webcast live on the Company’s website and will be available for playback at the following URL: https://ir.akoustis.com/news-events/ir-calendar.Akoustis’ high frequency, high performance XBAW® process and filters are experiencing growing...

Enrolling strategic expansion of ADXS-503 HOT program in NSCLC to explore potential to enhance and/or restore sensitivity to checkpoint inhibitorsSITC presentation from ongoing ADXS-503 Phase 1/2 clinical trial demonstrated disease control rate of 67% and overall response rate of 17% in first six evaluable patients with immediate prior progression on KEYTRUDA®Continued durable tumor control with two patients on treatment beyond 12 monthsStrengthened balance sheet through $9.2M public offering and utilization of common stock purchase agreement and at-the-market facilityPRINCETON, N.J., Jan. 25, 2021 (GLOBE NEWSWIRE) — Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products today announces its financial results for the fiscal year ended October...

HARTSVILLE, S.C., Jan. 25, 2021 (GLOBE NEWSWIRE) — Sonoco (NYSE:SON), one of the largest diversified global packaging companies, announced today that its Prepared and Specialty Foods Segment will raise prices for CPET (crystallized polyethylene terephthalate) and PP (polypropylene) thermoformed plastic trays and bowls by 8 percent. The increases will be applied individually, and depending on product category, effective for shipments beginning on February 22, 2021. “These price adjustments are critical to manage continued increases in cost across our business. Thus far, we have offset much of these increased input costs via manufacturing productivity initiatives and supply chain optimization activities, but with continued inflation, we must now pass this cost on to our customers,” said Rolfe Olsen, Segment Vice President – Prepared...

To Nasdaq Copenhagen A/S25 January 2021Merger of Nykredit Realkredit A/S and LR Realkredit A/SToday, the merger of Nykredit Realkredit A/S and LR Realkredit A/S was adopted by the general meetings of Nykredit Realkredit A/S and LR Realkredit A/S in accordance with the merger plan of 11 December 2020.On 18 January 2021, the Minister of Industry, Business and Financial Affairs approved the merger pursuant to section 204 of the Danish Financial Business Act, and today the merger was registered in the IT system of the Danish Business Authority.All the conditions for the completion of the merger have thus been fulfilled, and LR Realkredit A/S has as of today ceased to exist as a legal entity. At the same time, all of LR Realkredit A/S’ rights and obligations, including in relation to issued mortgage bonds and mortage loans, have transferred...

Til: Nasdaq Copenhagen A/S25. januar 2021Gennemførelse af fusion af Nykredit Realkredit A/S og LR Realkredit A/SFusionen mellem Nykredit Realkredit A/S og LR Realkredit A/S i henhold til fusionsplan af 11. december 2020 er i dag blevet godkendt af generalforsamlingen i både Nykredit Realkredit A/S og LR Realkredit A/S.Erhvervsministeren meddelte den 18. januar 2021 tilladelse til fusionen i henhold til § 204 i lov om finansiel virksomhed, og fusionen er i dag blev registreret i Erhvervsstyrelsens IT-system.Samtlige betingelser for fusionens gennemførelse er således opfyldte, og LR Realkredit A/S er derfor i dag ophørt som juridisk enhed. Samtidig er LR Realkredit A/S’ rettigheder og forpligtelser, herunder også i relation til udstedte realkreditobligationer og realkreditlån, overgået til Nykredit Realkredit A/S, jf. selskabslovens § 250.For...

Déclaration des transactions sur actions propresRéalisées du 18 au 22 janvier 2021Paris, le 25 janvier 2021Présentation agrégée par jour et par marchéPrésentation détaillée transaction par transaction  A propos de HighCoExpert en data marketing et communication, HighCo innove en permanence pour relever avec les marques et retailers les challenges du commerce de demain.Cotée sur le compartiment C d’Euronext Paris, et éligible au dispositif « PEA-PME », HighCo compte plus de 600 collaborateurs et fait partie depuis 2010 du Gaïa Index, sélection de 70 PME-ETI responsables.Vos contactsCécile COLLINA-HUE                                                      Cynthia LERATDirectrice Générale                                                           Relations Presse+33 1 77 75 65 06                                                             +33...

EMS Q4 2020 Bookings Nearly Double Over Q3 2020MT. LAUREL, N.J., Jan. 25, 2021 (GLOBE NEWSWIRE) — inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process solutions for use in manufacturing and testing across a wide range of markets, including automotive, defense/aerospace, energy, industrial, semiconductor and telecommunications, announced today that business in its EMS segment, which predominantly serves production test for analog and mixed signal semiconductor applications and has historically accounted for 15-30% of the Company’s annual revenue, has continued to experience a significantly improved order flow, with fourth quarter 2020 bookings nearly doubling over the 2020 third quarter’s EMS bookings.“We are seeing strength across the board in our EMS product offerings, driven by considerable...